Related Experiment Videos
24-month follow-up of multiple sclerosis patients treated with cyclophosphamide
E Millefiorini1, M Di Giovanni, S Bernardi
1Dipartimento di Scienze Neurologiche, Università La Sapienza, Roma.
Italian Journal of Neurological Sciences
|December 1, 1990
Abstract:
15 patients with remitting-progressive multiple sclerosis received a course of intravenous cyclophosphamide followed by a booster dose every 60 days for 2 years. There were no severe short or medium term side effects. Half of the patients presented clinical stabilization and substantially unchanged Kurtzke rating at 2 year follow-up. Since the aim was stabilization only, our findings argue for continuation of the study in young patients with very short shift.